Clinical Trial

Tamoxifen Versus Etoposide After First Recurrence in GBM Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The investigator propose a single-center randomized phase II controlled study designed to compare the management of first recurrence of GBM using etoposide versus tamoxifen.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-02-18; most recent amendment 2025-06-24.
Status change: Not Yet Recruiting → Recruiting 2022-03-28
Trial Details
NCT Number NCT04765098
Lead Sponsor AHS Cancer Control Alberta
Conditions Glioblastoma Multiforme
Enrollment 60 participants
Start Date 2022-01-28
Primary Completion 2026-12 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2025-06-26